Thornburg R W, Day J F, Baynes J W, Thorpe S R
J Biol Chem. 1980 Jul 25;255(14):6820-5.
The purpose of these experiments was to evaluate the hypothesis that galactose residues on IgG mediate the clearance of IgG.antigen complexes from the circulation. After 28 days of immunization of rats with bovine serum albumin (BSA), approximately 90% of anti-BSA antibody was IgG; the circulating half-life of trace amounts of BSA antigen in immunized rats was 6 min, compared to 24 h in nonimmunized rats. Similarly, soluble IgG.125I-BSA complexes formed in vitro, under conditions of antibody excess, had a circulating half-life of 4 min in normal rats. For both antigen in immunized rats, or IgG.125I-BSA complexes in normal animals, clearance was markedly inhibited by pre- or co-injection of asialofetuin, but was insensitive to large doses of fetuin, ovalbumin, or mannan. Liver parenchymal cells were the major site of uptake of complexes formed in vivo or in vitro. In vitro binding of IgG.125I-BSA complexes by isolated hepatocytes was effectively competed by asialofetuin, asialo-orosomucoid, galactose, and N-acetylgalactosamine, but was unaffected by fetuin, orosomucoid, ovalbumin, mannan, or mannose. These data suggest that antigen-induced conformational changes in IgG result in both recognition of galactose residues on IgG and clearance of IgG-immune complexes from the circulation by the galactose-specific receptor in hepatic parenchymal cells.
免疫球蛋白(IgG)上的半乳糖残基介导了IgG-抗原复合物从循环系统中的清除。用牛血清白蛋白(BSA)免疫大鼠28天后,约90%的抗BSA抗体为IgG;免疫大鼠中微量BSA抗原的循环半衰期为6分钟,而未免疫大鼠中为24小时。同样,在抗体过量条件下体外形成的可溶性IgG-125I-BSA复合物在正常大鼠中的循环半衰期为4分钟。对于免疫大鼠中的抗原或正常动物中的IgG-125I-BSA复合物,预先注射或同时注射去唾液酸胎球蛋白可显著抑制其清除,但对大剂量的胎球蛋白、卵清蛋白或甘露聚糖不敏感。肝实质细胞是体内或体外形成的复合物摄取的主要部位。去唾液酸胎球蛋白、去唾液酸血清类黏蛋白、半乳糖和N-乙酰半乳糖胺可有效竞争分离的肝细胞对IgG-125I-BSA复合物的体外结合,但胎球蛋白、血清类黏蛋白、卵清蛋白、甘露聚糖或甘露糖对此无影响。这些数据表明,抗原诱导的IgG构象变化导致对IgG上半乳糖残基的识别以及肝实质细胞中半乳糖特异性受体对循环中IgG免疫复合物的清除。